World AIDS Day 2023
While strides have been made in confronting HIV within the European Region, significant challenges remain in identifying and treating cases, as well as preventing infection in the first place. Expanding access to HIV testing and treatment, along with acknowledging and addressing the persistent HIV-related stigma and discrimination that prevents people from seeking diagnosis and care, are key steps to stop the rise in infection in several parts of the region.
ECDC and WHO reaffirm their commitment to supporting countries in accelerating progress toward reaching the Sustainable Development Goals for HIV. In close collaboration with partner organisations dedicated to reducing stigma, the focus will be on testing, treatment, and prevention activities, as well as enhancing surveillance and monitoring through dedicated guidance, workshops, webinars, and technical support.
Read the latest news
With more than 2.4 million people diagnosed, yet many others unaware of their status, critical action is needed.
Watch the press conference
ECDC held a press conference to present the latest data on HIV/AIDS surveillance in Europe.
Eurosurveillance: Rapid communication
Eurosurveillance is a peer-reviewed scientific journal devoted to the epidemiology, surveillance, prevention and control of communicable diseases.
Read the latest reports
Multimedia
Every year World AIDS Day is marked on the 1st of December. Beginning in 1988 as the first-ever international day for global health, it is now in its 35th year.
Juliana Reyes, ECDC's Expert in Communicable Diseases Prevention and Control, discusses the main challenges in addressing HIV/AIDS in Europe.
Anastasia Pharris, ECDC's Principal expert in Communicable Diseases, discusses the latest developments in HIV testing and detection.
Teymur Noori, ECDC's HIV Expert, explains how far along we are on the path to achieving the Sustainable Development Goals for HIV/AIDS.
HIV continues to affect the health and wellbeing of people in Europe. In 2020, 14,971 new HIV diagnoses were reported in 29 countries of the EU/EEA.
You may already know about PrEP, but did you know there is also PEP - the post-exposure prophylaxis - that is used after one may have been exposed to the HIV virus.
